Stock-Based Compensation - Analysis of Unvested Restricted Stock (Details) - shares	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Beginning Balance (in shares)	398,535	342,966	518,976
Grants (in shares)	194,864	166,202	156,789
Additional performance shares	(28,857)	(16,102)	(94,883)
Restriction lapses (in shares)	(100,887)	(87,031)	(226,866)
Forfeitures (in shares)	(17,010)	(7,500)	(11,050)
Ending Balance (in shares)	446,645	398,535	342,966
Executive Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Beginning Balance (in shares)	398,535	342,388	518,976
Grants (in shares)	81,300	146,500	139,500
Additional performance shares	(28,857)	(16,102)	(94,883)
Restriction lapses (in shares)	(84,298)	(66,751)	(210,155)
Forfeitures (in shares)	(12,600)	(7,500)	(11,050)
Ending Balance (in shares)	354,080	398,535	342,388
Directors Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Beginning Balance (in shares)	0	289	0
Grants (in shares)	7,110	10,746	10,031
Additional performance shares	0	0	0
Restriction lapses (in shares)	(7,110)	(11,035)	(9,742)
Forfeitures (in shares)	0	0	0
Ending Balance (in shares)	0	0	289
Directors Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Beginning Balance (in shares)	0	289	0
Grants (in shares)	9,479	8,956	7,258
Additional performance shares	0	0	0
Restriction lapses (in shares)	(9,479)	(9,245)	(6,969)
Forfeitures (in shares)	0	0	0
Ending Balance (in shares)	0	0	289
Employees Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares
Beginning Balance (in shares)	0	0	0
Grants (in shares)	96,975	0	0
Additional performance shares	0	0	0
Restriction lapses (in shares)	0	0	0
Forfeitures (in shares)	(4,410)	0	0
Ending Balance (in shares)	92,565	0	0